Phillips Edison & Company, Inc. PECO 深 沪
已收盘 02-06 16:00:00 美东时间
37.53
-0.290
-0.77%
华盛通- 最 高38.67
- 今 开37.79
- 成交量 164.07万股
- 最 低 37.325
- 昨 收 37.82
- 总市值 47.21亿
- 52周最高 38.67
- 市盈率 静 73.67
- 换手率 1.30%
- 52周最低 31.346
- 委 比 93.32%
- 总股本 1.26亿
- 历史最高 38.67
- 量 比 1.57
- 振 幅 3.56%
- 历史最低 21.2889
- 每 手 1
- 风险率 0.86%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | Phillips Edison & Company, Inc. 2025财年Q4营收1.88亿美元，同比增长8.6%；归母净利润0.48亿美元，同比增长162.0%
华盛资讯2月6日讯，Phillips Edison & Company, Inc.公布2025财年Q4业绩，公司Q4营收1.88亿美元，同比增长8.6%，归母净利润0.48亿美元，同比增长162.0%。
02-06 18:22
Phillips Edison Q4 EPS $0.38 Beats $0.15 Estimate, Sales $187.861M Beat $183.491M Estimate
Phillips Edison (NASDAQ:PECO) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0.15 by 160.27 percent. This is a 153.33 percent increase over earnings of $0.15 per share from
02-06 05:14
Earnings Scheduled For February 5, 2026
Companies Reporting Before The Bell • WEC Energy Group (NYSE:WEC) is estimated ...
02-05 19:11
美股大行评级 | 阿斯麦、美光科技、SanDisk获大行上调目标价；美国银行、富国银行绩后遭多家机构下调目标价
今日重点评级关注：Benchmark：维持TNL Mediagene"投机性买入"评级，目标价从3.5美元升至14美元；康托·菲茨杰拉德：维持Eupraxia Pharmaceuticals"超配"评级，目标价从11美元升至19美元
01-16 10:04
Evercore ISI Group Initiates Coverage On Phillips Edison & Co with Outperform Rating, Announces Price Target of $41
Evercore ISI Group analyst Michael Griffin initiates coverage on Phillips Edison & Co (NASDAQ:PECO) with a Outperform rating and announces Price Target of $41.
01-15 22:56
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
Morgan Stanley Maintains Equal-Weight on Phillips Edison & Co, Raises Price Target to $37
Morgan Stanley analyst Richard Hill maintains Phillips Edison & Co (NASDAQ:PECO) with a Equal-Weight and raises the price target from $36 to $37.
01-06 23:40
美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
Barclays Maintains Equal-Weight on Phillips Edison & Co, Raises Price Target to $42
Barclays analyst Richard Hightower maintains Phillips Edison & Co (NASDAQ:PECO) with a Equal-Weight and raises the price target from $40 to $42.
2025-12-19 00:04
